---
title: "BUZZ-Tempus AI climbs on $1.1 billion contract value"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/272259146.md"
datetime: "2026-01-12T11:16:41.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/272259146.md)
  - [en](https://longbridge.com/en/news/272259146.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/272259146.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/272259146.md) | [繁體中文](https://longbridge.com/zh-HK/news/272259146.md)


# BUZZ-Tempus AI climbs on $1.1 billion contract value

Shares of genetics-testing firm Tempus AI (TEM.O) up 10.4% at $73.19 premarket Reports record total contract value of over $1.1 bln and net revenue retention of ~126%

Says it signed data agreements with more than 70 customers in 2025, including AstraZeneca (AZN.L) , Pfizer (PFE.N) , Merck (MRK.N) and other major drugmakers

Co says engagement with life sciences firms at “record levels,” giving visibility to continued growth in 2026 and beyond

Preliminary 2025 data & applications revenue estimated at $316 mln, up ~31% YoY

Says FY prelim 2025 revenue about $1.27 billion, up roughly 83%

TEM stock gained ~76% over the past year

### 相关股票

- [Tempus AI (TEM.US)](https://longbridge.com/zh-CN/quote/TEM.US.md)

## 相关资讯与研究

- [Insig AI Plans Growth Drive and Eyes Nasdaq Dual Listing](https://longbridge.com/zh-CN/news/281311983.md)
- [Tempus AI Insider Sold Shares Worth $7,711,150, According to a Recent SEC Filing](https://longbridge.com/zh-CN/news/280974954.md)
- [MedPal AI Wins Strong Shareholder Backing at AGM as It Expands AI Health Platform](https://longbridge.com/zh-CN/news/281501359.md)
- [Tempus AI (TEM) Valuation Check After Daiichi Sankyo Oncology Collaboration Announcement](https://longbridge.com/zh-CN/news/281281204.md)
- [U.S. Startup Emergence AI Opens Research Hub in Bengaluru](https://longbridge.com/zh-CN/news/281141211.md)